DFTX

Definium Therapeutics, Inc.

NASDAQ: DFTX · HEALTHCARE · BIOTECHNOLOGY

$40.91

-9.39% today

Updated 2026-08-11

Market cap

$6.12B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.59

Dividend yield

—

52W range

$9 – $50

Volume

3.2M

Market cap

$6.12B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.59

Dividend yield

—

52W range

$9 – $50

Volume

3.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →212 stocks currently score above 75

Price targets

Analyst target

$60.12

+46.96%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

4 Strong Buy12 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-42.63M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-56.80M	$-95.73M	$-108.68M	$-183.79M	$-77.10M
EPS	—	—	—	—	$-2.59
Free cash flow	$-50.14M	$-64.36M	$-79.13M	$-131.56M	$-42.63M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
DFTX	$6.12B	25	4.3	3.0	5.0	6.0	—	Avoid
LLY	$1.02T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$614.36B	57	4.7	8.5	3.3	6.0	-87.34%	Buy
ABBV	$430.82B	73	6.7	8.5	4.7	5.0	-64.01%	Strong Buy
UNH	$370.11B	62	7.3	5.5	4.0	6.0	-28.08%	Buy
MRK	$316.14B	50	3.3	7.0	2.7	5.0	-60.87%	Hold

Smart narrative

Definium Therapeutics, Inc. trades at $40.91. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is Definium Therapeutics, Inc.'s stock price?

Definium Therapeutics, Inc. (DFTX) trades at $40.91.

Is Definium Therapeutics, Inc. overvalued?

Definium Therapeutics, Inc. carries a Smart Value Score of 25/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Definium Therapeutics, Inc. (DFTX)?

The 12-month analyst consensus target is $60.12, about 47.0% above the current $40.91. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-85.19%

Beta2.26

50D MA$36.56

200D MA$21.57

Shares out0.13B

Float0.11B

Short ratio—

Avg volume3.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

DFTX vs LLY →DFTX vs JNJ →DFTX vs ABBV →Stock screener →